BINDING OF [H-3] NITRENDIPINE TO CARDIAC AND CEREBRAL MEMBRANES FROM NORMOTENSIVE AND RENAL, DEOXYCORTICOSTERONE NACL AND SPONTANEOUSLY HYPERTENSIVE RATS

被引：26

作者：

ISHII, K ^{[1
]}

KANO, T ^{[1
]}

ANDO, J ^{[1
]}

YOSHIDA, H ^{[1
]}

机构：

[1] OSAKA UNIV,SCH MED,DEPT PHARMACOL 1,OSAKA 530,JAPAN

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1986年 / 123卷 / 02期

关键词：

D O I：

10.1016/0014-2999(86)90668-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：271 / 278

页数：8

共 23 条

[1]

BOLGER GT, 1983, J PHARMACOL EXP THER, V225, P291

[2]

CAMPBELL KP, 1984, J BIOL CHEM, V259, P5384

[3] COMPARISON OF [NITRENDIPINE-H-3 BINDING TO HEART MEMBRANES OF NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS [J].

CHATELAIN, P ;

DEMOL, D ;

ROBA, J .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (02) :220-223

[4] PURIFICATION OF THE CALCIUM-ANTAGONIST RECEPTOR OF THE VOLTAGE-SENSITIVE CALCIUM-CHANNEL FROM SKELETAL-MUSCLE TRANSVERSE TUBULES [J].

CURTIS, BM ;

CATTERALL, WA .

BIOCHEMISTRY, 1984, 23 (10) :2113-2118

[5] SPECIFIC BINDING OF [H-3]LABELED NITRENDIPINE TO MEMBRANES FROM CORONARY-ARTERIES AND HEART IN RELATION TO PHARMACOLOGICAL EFFECTS - PARADOXICAL STIMULATION BY DILTIAZEM [J].

DEPOVER, A ;

MATLIB, MA ;

LEE, SW ;

DUBE, GP ;

GRUPP, IL ;

GRUPP, G ;

SCHWARTZ, A .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (01) :110-117

[6]

EBSTEIN RP, 1982, CELL MOL NEUROBIOL, V2, P205, DOI 10.1007/BF00711148

[7] THE BINDING OF [H-3]-LABELED NITRENDIPINE TO RECEPTORS FOR CALCIUM-CHANNEL ANTAGONISTS IN THE HEART, CEREBRAL-CORTEX, AND ILEUM OF RATS [J].

EHLERT, FJ ;

ROESKE, WR ;

ITOGA, E ;

YAMAMURA, HI .

LIFE SCIENCES, 1982, 30 (25) :2191-2202

[8] IDENTIFICATION OF PUTATIVE CALCIUM CHANNELS IN SKELETAL-MUSCLE MICROSOMES [J].

FERRY, DR ;

GLOSSMANN, H .

FEBS LETTERS, 1982, 148 (02) :331-337

[9] PUTATIVE CALCIUM-CHANNEL MOLECULAR-WEIGHT DETERMINATION BY TARGET SIZE ANALYSIS [J].

FERRY, DR ;

GOLL, A ;

GLOSSMANN, H .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1983, 323 (04) :292-297

[10]

GOULD RJ, 1984, MOL PHARMACOL, V25, P235

← 1 2 3 →